MENU
ETNB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
89bio (ETNB) Ownership - Who owns 89bio?
Profile
Industry
N/A
Address
142 Sansome Street
Phone
+1 415 432-9270
Employees
70
Web
https://www.89bio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
932.43M
P/E Ratio
N/A
Total Cash
423.77M
Projected Growth
N/A
Total Debt
37.57M
Revenue
N/A
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash/Share
3.60
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ETNB
Capitalization
932M
P/E Ratio
N/A
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash
424M
Total Cash/Share
3.60
Total Debt
37.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
378M
P/B Ratio
2.47
Cash Flow
N/A
Earnings
-2.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
106K
Current Ratio
11.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-279.65M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-62.93
Shares Held By Institutions
1.53B
Shares Outstanding - Current
118M
Total Liabilities
80.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-28.917
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
142 Sansome Street
Phone
+1 415 432-9270
Employees
70
Web
https://www.89bio.com